{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:10:08Z","timestamp":1788966608115,"version":"build-2803163510"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background and purpose:<\/jats:title>\n                    <jats:p>PIM-1 kinase, a serine\/threonine kinase implicated in several cancers, has emerged as a promising yet underexplored target for anticancer therapy. This study aimed to identify the potential of PIM-1 inhibitors from marine natural products by integrating machine learning (ML)-based quantitative structure-activity relationship (QSAR) modeling with structure-based virtual screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental approach:<\/jats:title>\n                    <jats:p>Eleven ML models were developed and evaluated using experimentally validated ChEMBL data. The best-performing model was used to screen the Chemical Marine Natural Product Database (CMNPD), yielding 15 candidate compounds. Molecular docking prioritized four hits based on similarity of binding interactions at the catalytic site to the co-crystallized reference ligand, rather than on docking score alone. These hits were further assessed using 100 ns molecular dynamics (MD) simulations and MM\/GBSA binding free-energy calculations. ADMET profiling was also performed to evaluate pharmacokinetic and toxicity properties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings\/Results:<\/jats:title>\n                    <jats:p>\n                      Among the screened compounds, Hit-1 (CMNPD11687) emerged as the lead candidate. It showed stable binding throughout MD simulations, with an average RMSD of 4.10 \u00b1 1.67 \u00c5, low atomic fluctuations (RMSF), and favorable binding free energy (\u0394G-\n                      <jats:sub>Total<\/jats:sub>\n                      = -18.45 \u00b1 2.70 kcal\/mol). Hit-1 also maintained key protein-ligand interactions more consistently than the other hits. ADMET analysis predicted favorable drug-like and non-toxic properties.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and implications:<\/jats:title>\n                    <jats:p>These findings identified CMNPD11687 as a promising marine-derived scaffold for PIM-1 inhibition and demonstrated the value of combining ML-driven screening with molecular simulation to accelerate early-stage anticancer drug discovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/rps.rps_159_25","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:18:11Z","timestamp":1788949091000},"page":"618-631","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of PIM-1 kinase inhibitors from marine natural products through machine learning and structure-based screening"],"prefix":"10.4103","volume":"21","author":[{"given":"Bishal","family":"Budha","sequence":"first","affiliation":[{"name":"Department of Physics, Tri-Chandra Multiple Campus, Tribhuvan University, Kathmandu 44600, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Acharya","sequence":"additional","affiliation":[{"name":"Department of Physics, Tri-Chandra Multiple Campus, Tribhuvan University, Kathmandu 44600, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan","family":"Khanal","sequence":"additional","affiliation":[{"name":"Patan Multiple Campus, Tribhuvan University, Lalitpur 44700, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luthfi Ahmad","family":"Muchlashi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang 65145, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prisma Trida","family":"Hardani","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang 65145, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Salam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang 65145, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"1","key":"R1-20260909","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/14756366.2022.2135512","article-title":"Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR(WT) and EGFR(T790M) inhibitors","volume":"38","author":"Al-Warhi","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"7","key":"R2-20260909","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin Med J"},{"issue":"6835","key":"R3-20260909","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature."},{"issue":"3","key":"R4-20260909","doi-asserted-by":"crossref","first-page":"363","DOI":"10.21873\/cgp.20507","article-title":"The Role of ER stress and the unfolded protein response in cancer","volume":"22","author":"Ghemrawi","year":"2025","journal-title":"Cancer Genomics Proteomics."},{"key":"R5-20260909","doi-asserted-by":"crossref","first-page":"118117,1","DOI":"10.1016\/j.biopha.2025.118117","article-title":"Neuropeptide Y receptors 1 and 2 as molecular targets in prostate and breast cancer therapy","volume":"187","author":"Tomi\u0107","year":"2025","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"R6-20260909","doi-asserted-by":"crossref","first-page":"1635,1","DOI":"10.3390\/life13081635","article-title":"A PIM-1 kinase inhibitor docking optimization study based on logistic regression models and interaction analysis","volume":"13","author":"Ion","year":"2023","journal-title":"Life"},{"issue":"11","key":"R7-20260909","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/nm.4198","article-title":"PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer","volume":"22","author":"Bras\u00f3-Maristany","year":"2016","journal-title":"Nat Med"},{"issue":"9","key":"R8-20260909","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/omi.2021.0107","article-title":"Phytoconstituents and medicinal plants for anticancer drug discovery: computational identification of potent inhibitors of PIM1 kinase","volume":"25","author":"Anjum","year":"2021","journal-title":"OMICS."},{"issue":"1","key":"R9-20260909","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756366.2023.2166936","article-title":"Design, synthesis and cytotoxic evaluation of novel bis-thiazole derivatives as preferential Pim1 kinase inhibitors with in vivo and in silico study","volume":"38","author":"Al-Sanea","year":"2023","journal-title":"J Enzyme Inhibit Med Chem"},{"issue":"3","key":"R10-20260909","first-page":"123","article-title":"Recent research advances in small-molecule Pan-PIM inhibitors","volume":"14","author":"Xu","year":"2022","journal-title":"Pharm Front"},{"issue":"1","key":"R11-20260909","doi-asserted-by":"crossref","first-page":"18,1","DOI":"10.1186\/s12943-023-01721-1","article-title":"Targeting Pim kinases in hematological cancers: molecular and clinical review","volume":"22","author":"Bellon","year":"2023","journal-title":"Mol Cancer"},{"issue":"4-5","key":"R12-20260909","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14728222.2025.2500418","article-title":"Defeating kinases that promote tumorigenesis through non-catalytic functions with PROTACs - PIM kinase as an example","volume":"29","author":"Torres-Ayuso","year":"2025","journal-title":"Expert Opin Ther Targets"},{"issue":"14","key":"R13-20260909","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1074\/jbc.M413155200","article-title":"Pim-1 ligand-bound structures reveal the mechanism of serine\/threonine kinase inhibition by LY294002","volume":"280","author":"Jacobs","year":"2005","journal-title":"J Biol Chem"},{"issue":"6","key":"R14-20260909","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1021\/jm400045y","article-title":"A new target for an old drug: identifying mitoxantrone as a nanomolar inhibitor of PIM1 kinase via kinome-wide selectivity modeling","volume":"56","author":"Wan","year":"2013","journal-title":"J Med Chem."},{"issue":"13","key":"R15-20260909","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2174\/1871520622666220820090353","article-title":"Computational modelling strategies for exploring triazolopyridazine PIM1 kinase inhibitors as anticancer agents","volume":"25","author":"Walhekar","year":"2025","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"R16-20260909","doi-asserted-by":"crossref","first-page":"117866","DOI":"10.1016\/j.lfs.2020.117866","article-title":"A serine\/threonine protein PIM kinase as a biomarker of cancer and a target for anti-tumor therapy","volume":"255","author":"Panchal","year":"2020","journal-title":"Life Sci"},{"issue":"1","key":"R17-20260909","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/acs.jmedchem.3c01802","article-title":"Comprehensive insights that targeting PIM for cancer therapy: prospects and obstacles","volume":"67","author":"Chen","year":"2024","journal-title":"J Med Chem"},{"key":"R18-20260909","first-page":"S1359","article-title":"Pim kinase inhibitors in cancer: medicinal chemistry insights into their activity and selectivity","author":"Alnabulsi","year":"2020","journal-title":"Drug Discov Today"},{"issue":"28","key":"R19-20260909","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.2174\/0115680266321659240906114742","article-title":"PIM kinase inhibitors as novel promising therapeutic scaffolds in cancer therapy","volume":"24","author":"Karati","year":"2024","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"R20-20260909","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-20-0535","article-title":"Targeting PIM kinases to overcome therapeutic resistance in cancer","volume":"20","author":"Toth","year":"2021","journal-title":"Mol Cancer Ther"},{"issue":"41","key":"R21-20260909","doi-asserted-by":"crossref","first-page":"30346","DOI":"10.1039\/D4RA04036H","article-title":"Design, synthesis, biological evaluation, and docking studies of novel triazolo [4, 3- b] pyridazine derivatives as dual c-Met\/Pim-1 potential inhibitors with antitumor activity","volume":"14","author":"Mahmoud","year":"2024","journal-title":"RSC Adv"},{"issue":"2","key":"R22-20260909","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0975-7406.171700","article-title":"Exploring the ocean for new drug developments: marine pharmacology","volume":"8","author":"Malve","year":"2016","journal-title":"J Pharmacy and Bioallied Sci"},{"issue":"12","key":"R23-20260909","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.4155\/fmc.11.118","article-title":"Marine natural products: a new wave of drugs?","volume":"3","author":"Montaser","year":"2011","journal-title":"Future Med Chem"},{"issue":"18","key":"R24-20260909","first-page":"8320","article-title":"Kinase chemodiversity from the Arctic: the breitfussins","volume":"62","author":"Hansen","year":"2019","journal-title":"J Med Chem"},{"issue":"8","key":"R25-20260909","doi-asserted-by":"crossref","first-page":"1091,1","DOI":"10.3390\/ph16081091","article-title":"Therapeutic potential of marine probiotics: a survey on the anticancer and antibacterial effects of pseudoalteromonas spp","volume":"16","author":"Eze","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"12","key":"R26-20260909","doi-asserted-by":"crossref","first-page":"619,1","DOI":"10.3390\/md18120619","article-title":"Marine anticancer agents: an overview with a particular focus on their chemical classes","volume":"18","author":"Barreca","year":"2020","journal-title":"Mar Drugs"},{"issue":"4","key":"R27-20260909","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/md9040514","article-title":"Statistical research on marine natural products based on data obtained between 1985 and 2008","volume":"9","author":"Hu","year":"2011","journal-title":"Mar Drugs"},{"issue":"8","key":"R28-20260909","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1021\/cr300410v","article-title":"Kinase inhibitors of marine origin","volume":"113","author":"Bharate","year":"2013","journal-title":"Chem Rev"},{"issue":"D1","key":"R29-20260909","doi-asserted-by":"crossref","first-page":"D509","DOI":"10.1093\/nar\/gkaa763","article-title":"CMNPD: a comprehensive marine natural products database towards facilitating drug discovery from the ocean","volume":"49","author":"Lyu","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"R30-20260909","doi-asserted-by":"crossref","first-page":"162,1","DOI":"10.3390\/md16050162","article-title":"Ascidian toxins with potential for drug development","volume":"16","author":"Watters","year":"2018","journal-title":"Mar Drugs"},{"issue":"7","key":"R31-20260909","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/open.202400460","article-title":"Machine learning-based high-throughput screening, molecular modeling and quantum chemical analysis to investigate mycobacterium tuberculosis MetRS inhibitors","volume":"14","author":"Maharjan","year":"2025","journal-title":"ChemistryOpen"},{"issue":"12","key":"R32-20260909","first-page":"4977","article-title":"QSAR modeling: where have you been?","volume":"57","author":"Cherkasov","year":"2014","journal-title":"Where are you going to? J Med Chem."},{"issue":"7","key":"R33-20260909","doi-asserted-by":"crossref","first-page":"e0307501-e,1","DOI":"10.1371\/journal.pone.0307501","article-title":"Identification of potent inhibitors of HDAC2 from herbal products for the treatment of colon cancer: molecular docking, molecular dynamics simulation, MM\/GBSA calculations, DFT studies, and pharmacokinetic analysis","volume":"19","author":"Khanal","year":"2024","journal-title":"PLoS One"},{"key":"R34-20260909","doi-asserted-by":"crossref","first-page":"42717,1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"R35-20260909","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3934\/biophy.2024010","article-title":"Quantum chemical calculations on calcium oxalate and dolichin A and their binding efficacy to lactoferrin: an in silico study using DFT, molecular docking, and molecular dynamics simulations","volume":"11","author":"Acharya","year":"2024","journal-title":"AIMS Biophysics"},{"issue":"D1","key":"R36-20260909","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R37-20260909","article-title":"RDKit: open-source cheminformatics","author":"Landrum","year":"2013"},{"issue":"1-3","key":"R38-20260909","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deli Rev"},{"issue":"3","key":"R39-20260909","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput Sci Engin"},{"issue":"60","key":"R40-20260909","doi-asserted-by":"crossref","first-page":"3021,1","DOI":"10.21105\/joss.03021","article-title":"Seaborn: statistical data visualization","volume":"6","author":"Waskom","year":"2021","journal-title":"J Open Source Software"},{"key":"R41-20260909","article-title":"Data structures for statistical computing in Python. Proceedings of the 9th Python in Science Conference;2010","author":"McKinney"},{"issue":"5","key":"R42-20260909","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J Chem Inf Model"},{"key":"R43-20260909","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.toxlet.2023.01.006","article-title":"Development of predictive QSAR models for the substrates\/inhibitors of OATP1B1 by deep neural networks","volume":"376","author":"Gui","year":"2023","journal-title":"Toxicol Lett"},{"issue":"1","key":"R44-20260909","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1214\/aoms\/1177730491","article-title":"On a test of whether one of two random variables is stochastically larger than the other","volume":"18","author":"Mann","year":"1947","journal-title":"The Annals of Mathematical Statistics."},{"key":"R45-20260909","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J Machine Learning Res"},{"issue":"1","key":"R46-20260909","first-page":"37","article-title":"Evaluation: from precision, recall and F- measure to ROC, informedness, markedness and correlation","volume":"2","author":"Powers","year":"2011","journal-title":"J Machine Learning Technol"},{"issue":"2","key":"R47-20260909","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0005-2795(75)90109-9","article-title":"Comparison of the predicted and observed secondary structure of T4 phage lysozyme","volume":"405","author":"Matthews","year":"1975","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"R48-20260909","doi-asserted-by":"crossref","first-page":"33,1","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J Cheminform"},{"issue":"D1","key":"R49-20260909","first-page":"D271","article-title":"The RCSB Protein Data Bank: integrative view of protein, gene and 3D structural information","volume":"45","author":"Rose","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"R50-20260909","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/acs.jmedchem.8b01733","article-title":"Discovery of (R)-8-(6-Methyl- 4-oxo-1, 4, 5, 6-tetrahydropyrrolo [3, 4-b] pyrrol-2- yl)-3-(1 -methylcyclopropyl) -2-((1- methylcyclopropyl) amino) quinazolin-4 (3 H)-one, a Potent and Selective Pim-1\/2 Kinase Inhibitor for hematological malignancies","volume":"62","author":"Wang","year":"2019","journal-title":"J Med Chem"},{"issue":"16","key":"R51-20260909","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"issue":"2","key":"R52-20260909","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"R53-20260909","article-title":"BIOVIA Discovery Studio Visualizer, v20.1","author":"Dassault","year":"2020"},{"issue":"13","key":"R54-20260909","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera-a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"issue":"1","key":"R55-20260909","doi-asserted-by":"crossref","first-page":"e2400423,1","DOI":"10.1002\/ardp.202400423","article-title":"The discovery of a new nonbile acid modulator of Takeda G protein-coupled receptor 5:an integrated computational approach","volume":"358","author":"Salam","year":"2025","journal-title":"Arch Pharm"},{"issue":"16","key":"R56-20260909","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"issue":"25","key":"R57-20260909","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J Comput Chem"},{"issue":"12","key":"R58-20260909","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1021\/ci3003649","article-title":"Automation of the CHARMM general force field (CGenFF) II: assignment of bonded parameters and partial atomic charges","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J Chem Inf Model"},{"issue":"1","key":"R59-20260909","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J Cheminform"},{"issue":"10","key":"R60-20260909","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J Chem Theory Comput"},{"issue":"W1","key":"R61-20260909","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0:a web server for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"R62-20260909","doi-asserted-by":"crossref","first-page":"43,1","DOI":"10.1186\/1758-2946-5-43","article-title":"Similarity maps - a visualization strategy for molecular fingerprints and machine-learning methods","volume":"5","author":"Riniker","year":"2013","journal-title":"J Cheminformatics"},{"key":"R63-20260909","doi-asserted-by":"crossref","first-page":"509,1","DOI":"10.3389\/fchem.2019.00509","article-title":"Predicting synergism of cancer drug combinations using NCI-ALMANAC data","volume":"7","author":"Sidorov","year":"2019","journal-title":"Front Chem"},{"issue":"5","key":"R64-20260909","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/13543776.2024.2365411","article-title":"PIM kinase inhibitors: an updated patent review (2016-present)","volume":"34","author":"Sharma","year":"2024","journal-title":"Expert Opinion Ther Pat"},{"issue":"50","key":"R65-20260909","doi-asserted-by":"crossref","first-page":"41675","DOI":"10.1074\/jbc.M510711200","article-title":"Structure and substrate specificity of the Pim-1 kinase","volume":"280","author":"Bullock","year":"2005","journal-title":"J Biol Chem"},{"issue":"1","key":"R66-20260909","first-page":"13399,1","article-title":"Structural analysis of PIM1 kinase complexes with ATP-competitive inhibitors","volume":"7","author":"Bogusz","year":"2017","journal-title":"Scientific Rep"},{"issue":"20","key":"R67-20260909","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","article-title":"A critical assessment of docking programs and scoring functions","volume":"49","author":"Warren","year":"2006","journal-title":"J Med Chem"},{"issue":"18","key":"R68-20260909","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1039\/C6CP01555G","article-title":"Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power","volume":"18","author":"Wang","year":"2016","journal-title":"Phys Chem Chem Phys."},{"issue":"5","key":"R69-20260909","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"R70-20260909","first-page":"69","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods","volume":"51","author":"Hou","year":"2011","journal-title":"1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model"},{"issue":"3","key":"R71-20260909","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod."},{"issue":"1","key":"R72-20260909","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/md13010202","article-title":"Statistical research on the bioactivity of new marine natural products discovered during the 28 years from 1985 to 2012","volume":"13","author":"Hu","year":"2015","journal-title":"Marine Drugs"}],"container-title":["Research in Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/RPS.RPS_159_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:15:40Z","timestamp":1788963340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/RPS.RPS_159_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/rps.rps_159_25","relation":{},"ISSN":["1735-5362","1735-9414"],"issn-type":[{"value":"1735-5362","type":"print"},{"value":"1735-9414","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2025-10-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}